Free Webex Call
Global antimalarial drugs market is expected to register impressive growth during the forecast period, 2024-2028. Increasing prevalence of malaria coupled with surge in research for new antimalarial drugs is anticipated to propel the growth of the market. According to the “World Malaria Report 2021” by World Health Organization (WHO), in 2020, there were approximately 228 million cases and about 6,02,000 malaria-related deaths. Moreover, the increase in awareness initiatives by governments is also a key factor for growth of antimalarial drugs market. In 2021, the government of Malawi launched a 'Zero Malaria Starts with Me' campaign to stop malaria by the year 2030, which is the leading cause of death in Malawi.Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Additionally, rise in malaria death cases, especially in developing nations are also fueling the growth of antimalarial drugs market. According to World Health Organization (WHO), about half of the world's population is at risk of malaria.
Global antimalarial drugs market can be segmented based on drug type, drug class, route of administration, malaria type, application, distribution channel, company, and region. Based on drug class, the market is segmented into aryl aminoalcohol compounds, antifolate compounds, artemisinin compounds and antimicrobials. Among them, the aryl aminoalcohol compounds segment is expected to witness high growth during the forecast period owing to rising cases of malaria across the world.
Based on route of administration, the global antimalarial drugs market is segmented into oral, powder inhalation and intravenous administration. Among them, the oral segment is expected to undergo high growth through 2028 owing to the advantages such as safety, easy ingestion, pain avoidance and better patient compliance.
Major companies operating in global antimalarial drugs market include Cipla Ltd, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Merck & Co., Inc, Novartis AG, Zydus Cadila, Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), Strides Pharma Science Limited, Glenmark Pharmaceuticals Ltd., and Lincoln Pharmaceuticals Ltd. The market players are adopting growth strategies like new product launches, mergers & partnerships to increase their global market share.
Objective of the Study:
To analyze and forecast the market size of global antimalarial drugs market.To forecast global antimalarial drugs market based on drug type, drug class, route of administration, malaria type, application, distribution channel, company and regional distribution.
To identify drivers and challenges for global antimalarial drugs market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global antimalarial drugs market.
To identify and analyse the profile of leading players operating in the global antimalarial drugs market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, The research team sourced a list of antimalarial drugs companies across the globe. Subsequently, The research team conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies which could not be identified due to the limitations of secondary research.
The publisher calculated global antimalarial drugs market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. The research team sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used.
Key Target Audience:
- Antimalarial drugs companies/partners, investors, and other stakeholders
Hospital pharmacy/ retail pharmacy
- Government bodies such as regulating authorities and policy makers
- Organizations, industry associations, forums and alliances related to antimalarial drugs
Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as antimalarial drugs vendors, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.Report Scope:
In this report, global antimalarial drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:Global Antimalarial Drugs Market, By Drug Type:
- Quinine
- Chloroquine
- Proguanil
- Amodiaquine
- Mefloquine
- Hydroxychloroquine
- Pyrimethamine
- Others
Global Antimalarial Drugs Market, By Drug Class:
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- Antimicrobials
Global Antimalarial Drugs Market, By Route of Administration:
- Oral
- Powder Inhalation
- Intravenous Administration
Global Antimalarial Drugs Market, By Malaria Type:
- Plasmodium Falciparum
- Plasmodium Malariae
- Plasmodium Vivax
- Plasmodium Ovale
- Plasmodium Knowlesi
Global Antimalarial Drugs Market, By Application:
- Prevention
- Treatment of Malaria
Global Antimalarial Drugs Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- E-Commerce
- Others
Global Antimalarial Drugs Market, By Region:
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- North America
- United States
- Mexico
- Canada
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global antimalarial drugs market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:Company Information
Detailed analysis and profiling of additional market players (up to five).Profit Margin Analysis
Profit margin analysis in case of direct and indirect sales channel.This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Clinical Trial Analysis
6. Global Antimalarial Drugs Market Outlook
7. Asia-Pacific Antimalarial Drugs Market Outlook
8. Europe Antimalarial Drugs Market Outlook
9. North America Antimalarial Drugs Market Outlook
10. South America Antimalarial Drugs Market Outlook
11. Middle East and Africa Antimalarial Drugs Market Outlook
12. Market Dynamics
14. Competitive Landscape
Companies Mentioned
- Cipla Ltd
- GlaxoSmithKline Plc
- Ipca Laboratories Ltd.
- Merck & Co., Inc
- Novartis AG
- Zydus Cadila
- Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
- Strides Pharma Science Limited
- Glenmark Pharmaceuticals Ltd.
- Lincoln Pharmaceuticals Ltd.